Newsroom
17 November, 2026 / News / AI / Tags: evernorth, million, xrp, impairment, impairments

Ripple-backed firm cuts book value of 346 million tokens nearly 60% under historical-cost accounting rules that block recovery reversals
Evernorth Holdings, the publicly traded XRP treasury company backed by Ripple, has recorded cumulative impairment charges of approximately $505 million on its pre-listing XRP holdings, reducing their carrying value by nearly 60 percent. The adjustment appears in the company’s Form 10-Q filed with the U.S. Securities and Exchange Commission covering the period ended September 30, 2026.
As of that date, Evernorth held roughly 346 million XRP tokens originally recorded at about $847 million, or an average cost near $2.44 per token. After the impairments, the same holdings were carried on the balance sheet at approximately $342 million. The write-downs consist of $234 million recognized in 2025 and an additional $271 million in the first nine months of 2026, including $7 million in the third quarter alone.
The reduction is an accounting adjustment, not a sale of tokens. Evernorth has confirmed it did not dispose of any XRP as part of the impairment process. The company measures the assets as indefinite-lived intangible assets under a historical-cost model that subtracts impairment losses when the lowest observable intraday price on Coinbase falls below the recorded carrying amount for each lot acquired.
Because of Evernorth’s related-party relationship with Ripple, management determined that the holdings do not qualify for the newer fair-value accounting standard available to many other corporate crypto holders. Under that older treatment, once an impairment is recognized, subsequent price recoveries do not restore the book value. Any gains above the reduced carrying amount are recognized only upon sale.
At the September 30 closing price of nearly $1.50 on Coinbase, the same 346 million tokens would have carried a market value of about $516 million. The difference of roughly $174 million illustrates the gap created by the accounting rules rather than a realized cash loss.
| Metric | Amount |
|---|---|
| XRP holdings (Sept. 30) | Approximately 346 million |
| Original recorded value | $847 million |
| Carrying value after impairments | $342 million |
| Cumulative impairments | $505 million |
| Implied market value at $1.49 | $516 million |
For the nine months ended September 30, Evernorth reported a net loss of about $33 million. The result was partially offset by a $240 million noncash gain related to changes in the fair value of refundable investor advances. Operating expenses were dominated by the digital-asset impairment charges. The third quarter alone showed net income of $155 million, again supported by the noncash remeasurement.
Evernorth completed its business combination with a special-purpose acquisition company on October 9 and began trading on Nasdaq under the ticker XRPN on October 12. At the time of the merger closing, the company held approximately 473 million XRP after additional tokens were contributed, along with roughly $300 million in gross cash proceeds. A subsequent transfer of 346.5 million XRP to Pathfinder Digital Assets formed part of the post-merger corporate structure.
SPAC investors redeemed about 18.5 million shares for $195 million before closing, leaving approximately $48 million in the trust account. Updated pro forma figures for the combined entity as of September 30 showed total assets of about $419 million, of which $342 million represented digital assets at carrying value. Separate warrant exercises between mid-October and early November added more than 3 million Class A shares.
Following the listing, Evernorth announced partnerships with Ripple, Kraken, Coinbase and BitGo to support institutional investment strategies for its XRP treasury. The company has indicated it generates yield on a portion of its holdings from time to time, subject to market conditions, though it has not disclosed the volume of tokens deployed or the returns earned.
XRP has since traded below $1, recently near $0.90 to $0.96. Because impairment tests reference the lowest intraday price since acquisition, further write-downs remain possible in subsequent reporting periods if prices stay below previous lows. The company’s accounting policy continues to prevent automatic upward adjustments if the token recovers.
Evernorth has stated it has no intention of reversing the existing impairments even if XRP prices rise. The stock itself has declined substantially since its Nasdaq debut, reflecting broader market pressure on both the token and the newly listed treasury vehicle.
The September figures describe the pre-merger entity. Future quarterly reports will cover the combined public company and provide additional detail on treasury deployment, capital raises and any further valuation adjustments under the same accounting framework.









